SAGE meetings agenda search
Report from IVB Director including status of implementation of recommendations
Priorities, major policy and implementation issues: reports from AFRO, EMRO and SEARO
Polio eradication: feasibility of completion polio eradication and next steps: finding of November 2008 meeting of the ACPE; progress towards mobilizing community engagement for polio eradication in Nigeria: evidence of impact; new inter-provincial and inter-ministerial Government initiatives on polio eradication in Pakistan: evidence of impact; Update of the activities of the IPV Working Group
H5N1 influenza vaccine: report of the H5N1 Influenza Vaccine Working Group to SAGE: review of evidence and recommendations
Reports from other Advisory Committees in Immunization: GACVS, TLAC, QUIVER
Report from the GAVI secretariat
Hepatitis B vaccine: Evidence to support the use and timing of the hepatitis B birth dose for perinatal prevention of hepatitis B infection and evidence to support the current policy of not requiring booster doses of hepatitis B.
Impact of policy recommendations: report of a Stakeholder's panel.
Measles: Conclusions from 3rd Meeting of the SAGE Working Group on Measles and Draft recommendations for introduction of a second dose of measles vaccine delivered trough routine services; Assessing the feasibility of establishing a goal for global elimination of measles.
Review of updated safety, immunogenicity and efficacy data of rotavirus vaccines
Report from the Department on the progress made on previous SAGE recommendations and highlights on global progress.
Report from the Americas: focused on progress towards achieving the goals contained in the regional immunization vision and strategy
Report form the Europe: focused on 5 main issues: (i) AEFI and anti-immunization activities; (ii) introducing new vaccines and promoting underutilized vaccines; (iii) sustaining the polio-free status and eliminating measles and rubella; (iv) the impact of health sector reform on immunization; (v) the recent meeting of ETAGE.
Report from the Western pacific: focused on controlling Japanese encephalitis (JE)
Report from GAVI Alliance: key structural changes had been enacted: the GAVI Alliance Board and the GAVI Fund Board have been merged to create a new GAVI Alliance Board with a streamlined governance and committee structure.
Reports from other immunization-related advisory committees: GACVS, ECBS, IVAC and TLAC
H5N1 influenza vaccine: the SAGE working group-H5N1 reported on the outcome of its first meeting
HPV: SAGE was provided with a review that included evidence through September 2008 about the global burden of HPV-related, efficacy, immunogenicity and safety of prophylactic HPV vaccines, policies about and early experience with introduction of HPV vaccines, and the health benefits and cost-effectiveness of HPV vaccines
Measles: progress towards reaching the 2010 goal of reducing global measles mortality
Rotavirus vaccines: update on rotavirus introduction, surveillance activities and on immunogenicity and efficacy studies in Africa and Asia, including results from a preliminary analysis of the Rotarix trial in Malawi and South Africa.
Polio eradication: SAGE reviewed the India and Nigeria programmes
Beyond hepatitis B vaccine introduction: update on the work of the hepatitis B working group
Report from the Director, IVB
Update on developments in prequalification of vaccines and in national regulatory authority assessment
Regional priorities and major policy and implementation issues by AFRO, EMRO and SEARO
Reports from other immunization-related advisory committees: Polio Eradication, GACVS, QUIVER, GAVI)
Presentation of an updated draft of the vaccine position paper on the use of pneumococcal polysaccharide vaccine (PPV23)
Investment case for eliminating epidemic meningitis as a public health problem in Africa: Presentation of the strategy
WHO categorization of vaccine-preventable diseases project
Immunization schedules: description of the process that was followed to develop a draft of a consolidated table of all current WHO recommendations for vaccine administration
WHO's influenza-related activities
Immunization financing: update on the changing context of immunization financing with increasing efforts to introduce new vaccines
Report from the IVB: progress made on previous SAGE recommendations
Regional priorities and major policy and implementation issues (AMRO, EURO and WPRO)
Report from the GAVI Alliance: there has been strong growth in the introduction of new vaccines, with most eligible countries having been approved to introduce hepatitis B and Hib vaccines.
Target product profile for pneumococcal conjugate vaccines
Poliomyelitis eradication: New studies in India and Nigeria; outcomes of US NIH September 07 meeting; switch from OPV to IPV issues
Categorization of vaccine-preventable diseases
Potential uses of WHO H5N1 vaccine stockpile and H5N1 vaccine
Pneumococcal polysaccharide vaccine: A progress report on the status of the position paper on pneumococcal polysaccharide
Rabies vaccines: review of an updated position paper on rabies vaccines.
Typhoid fever vaccines: magnitude of the disease burden of typhoid fever and the m2 new-generation licensed vaccines (Vi polysaccharide and Ty21a).
Report from other advisory committees: GACVS, WHO's Expert Committee on Biological Standardization and the Advisory Committee of WHO's IVR: report of 2007 meeting of the HPV Expert Advisory group
Immunization safety: cross-departmental report: update of recent activities, progress and constraints on immunization-related waste management and injection safety
Report from the IVB: progress made on previous SAGE recommendations
Report from the GAVI Alliance: an update on recent GAVI activities
Regional priorities and major policy and implementation issues: AFRO, EMRO, SEARO
Global Advisory Committee on Vaccine Safety
Poliomyelitis eradication: outcomes of the Urgent Stakeholder Consultation on Polio Eradication, February 2007
Engaging on components of a WHO research strategy
Human papillomavirus vaccines
Optimization of immunization schedules: analysis conducted by the London School of Hygiene and Tropical Medicine
Stockpiling H5N1 influenza vaccine and establishing a mechanism for providing access to a pandemic vaccine for developing countries without influenza vaccine manufacturing capacity
Revised BCG vaccination guidelines for infants at risk for HIV infection
Report of the external review of advisory committees on immunization
Report form the IVB: progress made on previous SAGE recommendations
Report from the GAVI Alliance: achievements of Phase 1 funding
Regional priorities and major policy and implementation issues: AMRO, EURO, WPRO
Report from advisory committees: GACVS
Pandemic influenza vaccines: current situation of the H5N1 and the latest results in the development of H5N1 vaccines
Immunization financing and Advanced Market Commitments
Pneumococcal conjugate vaccines
Poliomyelitis eradication: impact of new international standards for polio-outbreak response and new eradication tools
Global framework on immunization monitoring and surveillance
Meningococcal vaccine: risk of short supply
Measles mortality reduction: adjustment of strategies
Optimizing immunization schedules: overview presentation of IVB's research agenda
Horizon scanning for HIV, tuberculosis and malaria vaccines
Report from the WHO IVB: progress in achieving previous SAGE recommendations and processes for monitoring there implementation
Immunization financing: focus on the existence and use of line items for the purchase of vaccines in national budgets
Regional priorities, major policy and implementation issues : AFRO, EMRO, SEARO
Reports from other immunization related advisory committees: GACVS, CBS, ACPE
Intermittent preventive treatment of infants for malaria, co-administered with immunization
Mumps vaccination: technical issues relating to the introduction and use of mumps vaccines in the WHO Eastern Mediterranean Region
Japanese encephalitis vaccination: surveillance data and disease burden, the impact of vaccination by several countries in SEARO
Update from the SAGE subgroup on pneumococcal vaccines
Update on optimization of immunization schedules and discussions on tetanus immunization
Report on pandemic influenza vaccine: current status of clinical trials with influenza pandemic vaccines, regulatory preparedness and summary work plan of WHO for 2006
Report on progress with implementation of immunization related activities
Measles mortality reduction: update and planning for future discussions on next global measles goals
Surveillance framework (GVS-MF)
Regional priorities, major policy and implementation issues
Reports from other immunization related advisory committees
GIVS: presentation of the outlines of the GIVS major strategic approaches and challenges for the implementation of the 4 strategic areas
Pandemic influenza preparedness and vaccination: update on the prospects of supply of pandemic influenza vaccines
Hib: morbidity and mortality of Hib pneumonia and meningitis in Africa and Asia and current national immunization recommendations
HPV vaccines: update on HPV vaccines, disease burden and planning for vaccine introduction
Conjugate pneumococcal vaccines: update on the current status; the incidence of invasive and non-invasive disease burdens; and the Pneumo ADIP
Optimizing immunization schedules
Rotavirus vaccines: update on current research and development
Progress report on implementation of 03 recommendations and highlights of 03-04 achievements
GIVS
Improving access to quality immunization services in Africa: Challenges and ways forward
Financial sustainability planning: update on the process
Synchronous cessation of oral poliovirus vaccine (OPV) use after Global Polio Eradication
Update on the global research and development agenda
Update on the MVP
Intellectual property rights and vaccines
Challenges for rotavirus vaccine
Update on progress and recent developments on measles mortality reduction and rubella control
Issues for the global prevention of invasive Hib diseases
Update on GAVI Hib recommendations
Quality challenges: acceptability of cell substrates
Regulatory and safety challenges
Report on the Global Vaccine Research Forum
Progress report on GAVI and WHO's role in the Alliance
Polio eradication strategic approach for 2003: revisions and risks
Report of the 4th Steering Committee of the Immunization Safety Priority Project
Promoting synergies between WHO standards setting and WHO product development activities
Vaccine quality
Reference preparations for batch release of vaccines
Steering Committee on Epidemiology and Field Research
Meningitis: trivalent Nm A/C/W polysaccharide vaccine impact assessment
The Meningitis Vaccine Project (MVP) - an update
HIV vaccine development: lessons from the first phase III trial
New delivery systems for measles vaccine
Immunization financing: What should we be doing?
Orientation of field staff in polio-free countries to strengthen routine immunization services
SARS: Do we need a vaccine to control it?
Opportunities for integrating anthelmintic treatment into immunization services
Accelerated vaccine introduction priority project
Next steps in the introduction of Hib in Asia
Improving vaccine management performance at country level
Report of the Global Advisory Committee on Vaccine Safety
Measles: 2003 WHA resolution on measles mortality reduction
Polio eradication - expanding the benefits: progress to date and strategic direction for 04-08
Polio eradication - the role of IPV
Vitamin A: update on activities
Yellow fever control and prevention: progress and issues
Maternal and neonatal tetanus: outcome of adhoc advisory meeting, March 03
Controlling rubella and preventing congenital rubella in the Americas and Europe
agenda search